Education
About Us
Working with TipRanks
Follow Us
Connect Biopharma Holdings (CNTB)
NASDAQ:CNTB
RESEARCH TOOLSreports
Total Valuation
Connect Biopharma Holdings has a market cap or net worth of $38.73M. The enterprise value is -$17.37M.
Market Cap$38.73M
Enterprise Value-$17.37M
Share Statistics
Connect Biopharma Holdings has 55,349,210 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding55,349,210
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Connect Biopharma Holdings’s return on equity (ROE) is -0.59 and return on invested capital (ROIC) is -61.03%.
Return on Equity (ROE)-0.59
Return on Assets (ROA)-0.47
Return on Invested Capital (ROIC)-61.03%
Return on Capital Employed (ROCE)-0.61
Revenue Per Employee0.00
Profits Per Employee-957.79K
Employee Count62
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Connect Biopharma Holdings is -1.09. Connect Biopharma Holdings’s PEG ratio is 0.01.
PE Ratio-1.09
PS Ratio―
PB Ratio0.64
Price to Fair Value0.64
Price to FCF-1.35
Price to Operating Cash Flow-1.36
PEG Ratio0.01
Income Statement
In the last 12 months, Connect Biopharma Holdings had revenue of 0.00 and earned -59.50M in profits. Earnings per share was -1.08.
Revenue0.00
Gross Profit-988.00K
Operating Income-62.07M
Pretax Income-59.38M
Net Income-59.50M
EBITDA-58.37M
Earnings Per Share (EPS)-1.08
Cash Flow
In the last 12 months, operating cash flow was -24.82M and capital expenditures -444.33K, giving a free cash flow of -25.26M billion.
Operating Cash Flow-24.82M
Free Cash Flow-25.26M
Free Cash Flow per Share-0.46
Dividends & Yields
Connect Biopharma Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.42
52-Week Price Change-50.36%
50-Day Moving Average0.79
200-Day Moving Average1.07
Relative Strength Index (RSI)47.38
Average Volume (3m)179.69K
Important Dates
Connect Biopharma Holdings upcoming earnings date is Sep 16, 2025, TBA Not Confirmed.
Last Earnings DateMar 31, 2025
Next Earnings DateSep 16, 2025
Ex-Dividend Date―
Financial Position
Connect Biopharma Holdings as a current ratio of 4.99, with Debt / Equity ratio of 0.29%
Current Ratio4.99
Quick Ratio4.99
Debt to Market Cap0.00
Net Debt to EBITDA1.81
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Connect Biopharma Holdings has paid 120.00K in taxes.
Income Tax120.00K
Effective Tax Rate>-0.01
Enterprise Valuation
Connect Biopharma Holdings EV to EBITDA ratio is 0.69, with an EV/FCF ratio of 0.84.
EV to Sales0.00
EV to EBITDA0.69
EV to Free Cash Flow0.84
EV to Operating Cash Flow0.85
Balance Sheet
Connect Biopharma Holdings has $110.24M in cash and marketable securities with $127.96K in debt, giving a net cash position of -$109.92M billion.
Cash & Marketable Securities$110.24M
Total Debt$127.96K
Net Cash-$109.92M
Net Cash Per Share-$1.99
Tangible Book Value Per Share$1.83
Margins
Gross margin is 98.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin98.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Connect Biopharma Holdings is $7.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$7.00
Price Target Upside900.00% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast―
EPS Growth Forecast―